Sign In

Press release centre

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.

Past Press Releases - AlgoNomics (acquired by Lonza Group)

November 3, 2009
Lonza integrates Innovative Technology in its Protein Design Services offering
Lonza strengthens its protein design technology offering for biopharmaceutical development by acquiring Algonomics NV (Gent, Belgium). More

December 19, 2007
AlgoNomics appoints Philippe Stas as CEO
AlgoNomics NV, the immunoprofiling company, announced today the promotion of Philippe Stas to Chief Executive Officer. Dr. Ignace Lasters, who previously held the position of CEO, will continue as Chief Scientific Officer and assume a role as director of the company. Mr. Stas will concentrate on the continued global expansion of AlgoNomics as a specialty service provider for immunogenicity screening. More

December 11, 2006
VIB and AlgoNomics to address protein immunogenicity
AlgoNomics to expand its Epibase immunogenicity screening services with VIB screening technology. More

October 9, 2006
Alligator Bioscience to address immunogenicity with Epibase®
Alligator Bioscience AB and AlgoNomics NV today announced that they have entered into a collaboration. More

July 12, 2006
MAT Biopharma to enter in a research collaboration with AlgoNomics
MAT Biopharma SA and AlgoNomics NV today announced they entered into a research collaboration. AlgoNomics will employ its structural bioinformatics platform to assist MAT Biopharma in its research related to the structural analysis of its antibody leads. The research collaboration focused on increasing the structural insight and potential immunogenicity of antibodies against hematological cancer and some solid cancers. More

April 25, 2006
AlgoNomics to receive Frost & Sullivan 2006 Technology Innovation Award
Proprietary Epibase® platform lauded as pioneering technology platform in the screening for immunogenicity of protein therapeutics. More

February 2, 2006
AlgoNomics releases immunoprofiling platform with global population coverage
AlgoNomics NV today announced the extension of its Epibase® platform for T-cell epitope identification. The immunoprofiling platform is a proprietary tool designed to select protein therapeutics that show the lowest risk for complications related to immunogenicity. Immunogenicity can lead to severe adverse effects and can reduce the efficacy of protein therapeutics.

May 12, 2005
Genmab to access AlgoNomics’ Epibase platform
AlgoNomics NV announced today it had entered into an agreement granting Genmab A/S access to AlgoNomics’ Epibase platform for T-cellepitope identification. More


Tech investments
From our Online Data Service
VC-backed companies
From our Radar

Recent Deals

Nov 25€24.0MInternet commerce
Jan 10€20.0MBusiness applications
Jan 10€20.0MBiotechnology
Jan 10€13.5MArtificial Intelligence
Jan 9€4.0MSoftware development
Jan 9N/AInternet services
Jan 9€15.0MBusiness applications

For information on Europe's most extensive database on technology funding click here!


Press Releases

May 28
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
nethone raised over $1 million from innovation nest

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

Jan 2
Urban Jungle
urban jungle raises £1m in seed funding to build tech-enabled home ...

About usContact usLegal Information
Copyright © 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.